Two Years Into Supplement GMPs, Many Firms Remain Ill-Equipped
This article was originally published in The Tan Sheet
Executive Summary
FDA inspectors find supplement manufacturers improperly maintaining and calibrating production equipment – in some cases, failing to adequately clean machines between running separate products.
You may also be interested in...
As Supplement GMP Implementation Hits Zero Hour, Small Firms Still Struggle
FDA's final rule for dietary supplement good manufacturing practices completed its phase-in for the industry June 25, and the agency now prepares to conduct inspections of small firms, which have struggled the most to comply with the regulation
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.